CardiaLen's Series A Round

CardiaLen raised a round of funding on January 13, 2014.

CardiaLen develops and commercializes pain-free cardioversion therapy, with a primary focus on atrial fibrillation (AF). The company is developing implantable low-energy (low voltage) pain-free atrial…

Articles about CardiaLen's Series A Round: